Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 17, 2024Respirology

Efficacy of varenicline or bupropion and its association with nicotine metabolite ratio among smokers with COPD

View Full Paper
Ask AI
Bookmark
Share

Authors

RQRui QinZLZhao LiuACAnqi Cheng

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Qin et al. (2024) studied this question.

synapsesocial.com/papers/68e73a87b6db6435876b41dehttps://doi.org/10.1111/resp.14702
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Nicotine metabolite ratio as an informed biomarker to optimize acupuncture for smoking cessation: randomised controlled trial2024
  2. 2Efficacy of bupropion and varenicline genetic markers in choosing pharmacological treatment for smoking cessation, and implications for combining drugs: A randomized controlled trial (GENTSMOKING)2024 · 1 citations
  3. 3Cost-effectiveness of nicotine metabolite ratio-guided smoking cessation therapy in China: a hybrid decision-analytic modeling study based on real-world data2026
  4. 4Smoking cessation effectiveness in smokers with obstructive respiratory disease2011
  5. 5Varenicline versus nicotine replacement therapy for long-term smoking cessation: an observational study using the Clinical Practice Research Datalink2020 · 13 citations